Tobacco Regulatory Science (R01 Clinical Trial Optional)
ID: 347922Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $500K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/347922

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-OD-23-017.html
Timeline
  1. 1
    Forecast Posted Not available
  2. 2
    Forecast Due Not available
  3. 3
    Posted May 3, 2023, 12:00 AM UTC
  4. 4
    Due May 4, 2025, 12:00 AM UTC
Description

The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) titled "Tobacco Regulatory Science (R01 Clinical Trial Optional)" aimed at advancing research that informs the regulation of tobacco products to protect public health. This initiative invites R01 applications for biomedical and behavioral research projects that align with the regulatory priorities of the FDA's Center for Tobacco Products, focusing on areas such as product composition, toxicity, addiction, and health effects related to tobacco use. Funding is available for up to six grants, with a maximum direct cost of $500,000 per year for a duration of five years, totaling up to $4 million. Interested applicants must submit their proposals by May 2, 2025, and can find additional information and application instructions at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.

Point(s) of Contact
grantsinfo@nih.gov
Files
Title
Posted
RFA-OD-23-017-Full-Announcement.html
Aug 24, 2024, 2:22 AM UTC
RFA-OD-23-017.html
Aug 24, 2024, 2:22 AM UTC
The Department of Health and Human Services, through the National Institutes of Health (NIH) and FDA, has announced a Notice of Funding Opportunity (NOFO), RFA-OD-23-017, aimed at advancing tobacco regulatory science. This initiative invites applications for R01 research projects focusing on biomedical and behavioral studies that will provide scientific evidence to enhance the regulation of tobacco products in accordance with the FDA's authority under the Family Smoking Prevention and Tobacco Control Act. The objectives include exploring product composition, toxicity, addiction, health effects, and communication strategies concerning tobacco use. Applications must align with specific scientific domains related to tobacco regulation and may address populations at disproportionate risk from tobacco use. Funding is available up to $4 million for six R01 grants, with a direct cost limit of $500,000 per year over a maximum of five years. Key dates include an application start date of September 6, 2023, and a submission deadline of May 2, 2025. Potential applicants are encouraged to review detailed application instructions and ensure compliance with all submission requirements, including the incorporation of data management and sharing plans as per recent NIH policies. The successful proposals will influence FDA regulatory practices to better protect public health.
Similar Opportunities
High-Priority Research in Tobacco Regulatory Science (R01 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) is offering a funding opportunity for "High-Priority Research in Tobacco Regulatory Science" aimed at advancing scientific understanding of tobacco products to inform regulations by the Food and Drug Administration (FDA). This initiative invites R01 applications focused on critical research areas, including addiction, health impacts, and the toxicity of electronic nicotine delivery systems (ENDS) and other tobacco products. The funding is crucial for generating data that will guide FDA's regulatory decisions, ultimately protecting public health. Each application can request up to $500,000 per year for a project period of up to five years, with a total of $4 million available across five awards. Applications are due by June 7, 2025, and interested parties can contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
Notice of Intent to Publish a Notice of Funding Opportunity (NOFO) for High-Priority Research in Tobacco Regulatory Science (R01 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) plans to publish a Notice of Funding Opportunity (NOFO) for High-Priority Research in Tobacco Regulatory Science, inviting R01 research applications that focus on biomedical and behavioral research to inform tobacco product regulation. This initiative aims to generate scientific data that will enhance public health protections related to tobacco use, with a particular emphasis on fostering diverse perspectives through a simplified peer review framework. The total estimated funding for this program is $4 million, with an award ceiling of $500,000 for each of the anticipated five awards, and the NOFO is expected to be published in Winter 2024, with applications due in Summer 2025. Interested applicants should prepare to submit new applications, as only new proposals will be considered, and further details will be available upon the official release of the NOFO.
Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R01 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) is offering a grant opportunity titled "Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R01 Clinical Trial Optional)" aimed at supporting research projects that evaluate policies related to tobacco, alcohol, and cannabis use in the United States. The initiative focuses on understanding how these policies impact substance use and secondhand exposure among populations experiencing health disparities, with an emphasis on community engagement to enhance cancer prevention efforts. Eligible applicants include a wide range of organizations such as higher education institutions, nonprofits, and government entities, with funding available up to $500,000 per year for a maximum of five years. Interested parties can find more information and application details at the NIH grants website, with the application deadline set for January 7, 2028.
Notice of Intent to Publish a Funding Opportunity Announcement for Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R01 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for research projects focused on health equity related to tobacco, alcohol, and cannabis policies. This initiative aims to address disparities in exposure and use of these substances by examining new or adapted policies in the U.S., with the goal of advancing equitable health policies. The funding opportunity will utilize the R01 grant mechanism, which is optional for clinical trials, and is expected to open for applications in February 2025, with a funding ceiling of $499,999. Interested applicants should prepare their proposals in advance, as the NOFO is anticipated to be published in September 2024, and further details, including a pre-application webinar, will be announced following the publication.
Data Standards for Tobacco Research and Scientific Review Phase 2
Food and Drug Administration
The Food and Drug Administration (FDA) is forecasting a cooperative agreement opportunity titled "Data Standards for Tobacco Research and Scientific Review Phase 2," aimed at enhancing tobacco research and improving public health outcomes related to tobacco use. The primary objective of this initiative is to develop open, consensus-based data standards for studies on tobacco products, while also promoting education on standardized data usage among federal regulators, the tobacco industry, and global organizations. This funding opportunity, categorized under consumer protection, has an estimated total program funding of $400,000, with two awards expected to be granted. Interested applicants, particularly small businesses, should note that the synopsis is anticipated to be posted on October 1, 2023, with a closing date of December 1, 2023, and projects are expected to commence on May 1, 2024. For further inquiries, applicants can contact Rene A. Vasquez, Grants Management Specialist, at 301-796-3546 or via email at rene.vasquez@fda.hhs.gov.
Notice of Intent to Publish a Funding Opportunity Announcement for Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R21 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for pilot and exploratory research projects focused on health equity related to tobacco, alcohol, and cannabis use. The initiative aims to investigate disparities in exposure and usage of these substances by examining new or adapted policies in the U.S., with the goal of advancing equitable health policies. This funding opportunity will utilize the R21 grant mechanism, which supports early-stage research, and is expected to be published in September 2024, with the first application deadline in March 2025. Interested applicants should prepare their proposals in advance, as the estimated award date is December 1, 2025, and further details, including a pre-application webinar, will be announced following the NOFO publication.
Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R21 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) is offering a funding opportunity titled "Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R21 Clinical Trial Optional)" aimed at supporting policy research projects that investigate the impact of tobacco, alcohol, and cannabis policies on health disparities in the U.S. The initiative seeks exploratory research that engages community organizations to promote equity in cancer prevention by addressing substance use and exposure among disadvantaged populations. This grant program, with an estimated total funding of $200,000 and an award ceiling of $200,000, emphasizes the importance of community partnerships and diverse research team perspectives. Applications are due by January 7, 2028, and interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-25-241.html.
Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) is offering a funding opportunity titled "Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders" (R34 Clinical Trial Optional). This initiative encourages pilot studies aimed at preparing for larger-scale effectiveness trials that focus on optimizing access, quality, and affordability of substance use disorder treatments and related services, with an emphasis on diverse perspectives through a Plan for Enhancing Diverse Perspectives (PEDP). Applicants may request up to $450,000 in direct costs for a three-year grant, with application due dates beginning January 16, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-25-100.html.
Notice of Intent to Publish a Funding Opportunity Announcement for Scaling-up and Maintaining Evidence-based Interventions to Maximize Impact on Cancer (SUMMIT) - Tobacco Use Treatment for Cancer Survivors (UG3/UH3 Clinical Trial Required)
National Institutes of Health
The National Institutes of Health (NIH) plans to publish a Notice of Funding Opportunity (NOFO) for the Scaling-up and Maintaining Evidence-based Interventions to Maximize Impact on Cancer (SUMMIT) initiative, specifically targeting Tobacco Use Treatment for Cancer Survivors. This initiative aims to fund up to three research projects that will develop and test strategies to enhance the delivery and sustainability of tobacco use treatment services for cancer survivors, utilizing the UG3/UH3 Exploratory/Developmental Cooperative Agreement activity code, which requires clinical trials. The total estimated funding for this opportunity is $2.4 million, with applications expected to be due in late Fall 2024 and awards anticipated by July 1, 2025. Interested applicants are encouraged to prepare by reviewing related materials and attending a pre-application webinar, details of which will be announced following the NOFO publication.
Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) has announced a funding opportunity for the Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional), aimed at supporting research in the development and testing of behavioral treatments for substance misuse and dependence. This grant focuses on Stage I research, which includes the development and pilot testing of novel interventions or the refinement of existing treatments, with an emphasis on scalability and effectiveness in community applications. The initiative is crucial for advancing effective treatment methods for substance use disorders, ensuring they are robust and applicable to diverse populations. Eligible applicants can receive up to $450,000 for a three-year project period, with applications due by May 7, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-24-300.html.